Induction of HL-60 cell differentiation by the p38 mitogen-activated protein kinase inhibitor SB203580 is mediated through the extracellular signal-regulated kinase signaling pathway

Anti-Cancer Drugs

Volumn 14, Issue 1, 2003, Pages 31-38

  Zhang, Jin Xia ^a   Zhuang, Wie Jian ^a   Poon, Ka Hung ^a   Yang, Michael ^a   Fong, Wang Fun ^a  

^a CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Differentiation; HL 60; Mitogen activated protein kinase; p38 kinase; p38 kinase inhibitor; SB203580

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD11B ANTIGEN; CD14 ANTIGEN; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; SYNAPTOPHYSIN;

ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL NUCLEUS; CELL STRAIN HL 60; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; NUCLEOLUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; IMIDAZOLES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; SIGNAL TRANSDUCTION;

EID: 0037265010     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200301000-00005     Document Type: Article

References (25)

1. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994; 369:156-160.
2. Minden A, Lin A, Smeal T, Derijard BN, Cobb M, Davis R, et al. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol 1994; 14:6683-6688.
3. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, et al. Proinflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270:7420-7426.
4. Ono K, Han JH. The p38 signal transduction pathway activation and function. Cell Signal 2000; 12:1-13.
5. Lee JC, Griswold DE, Votta B, Hanna N. Inhibition of monocyte IL-1 production by the anti-inflammatory compound SK&F 86002. Int J Immunopharmacol 1988; 10:835-843.
6. Gallagher TF, Fier-Thompson SM, Garigipati RS, Sorenson ME, Smietana JM, Lee D, et al. 2,4,5-Triarylimidazole inhibitors of IL-1 biosynthesis. Bioorg Med Chem Lett 1995; 5:1171-1176.
7. Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL, Griswold DE. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 1996; 279:1453-1461.
8. Gallagher TF, Seibel GL, Kassis S, Laydon JT, Lee JC, Lee D, et al. Regulation of stress-induced cytokine production by pyridinylimidazoles: inhibition of CSBP kinase. Bioorg Med Chem 1997; 5:49-64.
9. Prichett W, Hand A, Sheilds J, Dunnington D. Mechanism of action of bicyclic imidazoles defines a translational regulatory pathway for tumor necrosis factor alpha. J Inflamm 1995; 45:97-105.
10. Kalmes A, Deou J, Clowes AW, Daum G. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB 203580. FEBS Lett 1999; 444:71-74.
11. 3-induced differentiation of human leukemia HL60 cells. Exp Cell Res 2000; 258:425-437.
12. Wang X, Studzinski GP. Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells. J Cell Biochem 2001; 82:68-77.
13. New L Li YQ, Ge BX, Zhong HY, Mansbridge J, Liu K, et al. SB203580 promote EGF-stimulated early morphological differentiation in PC12 cell through activation ERK pathway. J Cell Biochem 2001; 83:585-596.
14. Yuki I, Shingo S, Yoshio H. Pyridinyl imidazole inhibitor SB203580 activates p44/p42 mitogen-activated protein kinase and induces the differentiation of human myeloid leukemia cells. Leuk Res 2001; 25:813-820
15. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 1995; 270:27489-27494.
16. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372:739-746.
17. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, et al. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and inteleukin-1. FEBS Lett. 1995; 364:229-233.
18. Schultz H, Engel K, Gaestel M. PMA-induced activation of the p42/p44 and p38 MAP kinase cascades in HL-60 cells is PKC dependent but not essential for differentiation to the macrophage like phenotype. J Cell Physiol 1997; 274:310-318.
19. Meher P. p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation. J Biol Chem 1999; 274:17491-17498.
20. Frantz B, Klatt T, Pang M, Parsons J, Rolando A, Williams H, et al. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry 1998; 37:13846-13853.
21. Yen A, Roberson MS, Varvayanis S, Lee AT. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrested. Cancer Res 1998; 58:3163-3172.
22. Yen A, Roberson MS, Varvayanis S. Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinase when inducing myeloid differentiation. In vitro Cell Dev Biol Anim 1999; 35:527-532.
23. Hall-Jackson CA, Goedert M, Hedge P, Cohen P. Effect of SB203580 on the activity of c-Raf in vitro and in vivo. Oncogene 1999; 18:2047-2054.
24. 3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Biochem Biophys Res Commun 1997; 241:419-426.
25. Kharbanda S, Saleem A, Emoto Y, Stone R, Rapp U, Kufe D. Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells. J Biol Chem 1994; 269:872-878.